The majority of the patients were lacking the golden drug in management: beta-blockers in mitral stenosis, ACE inhibitors or ARBs in mitral and aortic regurgitation, and digoxin, antiplatelets, and statins in aortic stenosis. The gene discussed is ACE; the disease is mitral valve stenosis.